Filtros : "GRU999" "Sanfard Burnham Prebys Medical Discovery Institute – National Cancer Institute/NCI, Designated Cancer Center, La Jolla, CA, USA" Removido: "APRESENTACAO SONORA/CENICA/ENTREVISTA" Limpar

Filtros



Refine with date range


  • Source: Bioscience Reports. Unidade: IQ

    Subjects: NEOPLASIAS, SISTEMA IMUNE, RECEPTORES

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VELLOSO, Fernando Janczur et al. NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer. Bioscience Reports, v. 39, n. 4, p. 1-21 art. BSR20181709, 2019Tradução . . Disponível em: https://doi.org/10.1042/BSR20181709. Acesso em: 14 jun. 2024.
    • APA

      Velloso, F. J., Trombetta-Lima, M., Anschau, V., Sogayar, M. C., & Correa, R. G. (2019). NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer. Bioscience Reports, 39( 4), 1-21 art. BSR20181709. doi:10.1042/BSR20181709
    • NLM

      Velloso FJ, Trombetta-Lima M, Anschau V, Sogayar MC, Correa RG. NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer [Internet]. Bioscience Reports. 2019 ; 39( 4): 1-21 art. BSR20181709.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1042/BSR20181709
    • Vancouver

      Velloso FJ, Trombetta-Lima M, Anschau V, Sogayar MC, Correa RG. NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer [Internet]. Bioscience Reports. 2019 ; 39( 4): 1-21 art. BSR20181709.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1042/BSR20181709
  • Source: BMC Genomics. Unidade: IQ

    Subjects: PROTEÔMICA, NEOPLASIAS MAMÁRIAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VELLOSO, Fernando Janczur et al. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation. BMC Genomics, v. 20, n. 1, p. 1-20 art. 152, 2019Tradução . . Disponível em: https://doi.org/10.1186/s12864-019-5523-6. Acesso em: 14 jun. 2024.
    • APA

      Velloso, F. J., Campos, A. R., Sogayar, M. C., & Correa, R. G. (2019). Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation. BMC Genomics, 20( 1), 1-20 art. 152. doi:10.1186/s12864-019-5523-6
    • NLM

      Velloso FJ, Campos AR, Sogayar MC, Correa RG. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation [Internet]. BMC Genomics. 2019 ; 20( 1): 1-20 art. 152.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1186/s12864-019-5523-6
    • Vancouver

      Velloso FJ, Campos AR, Sogayar MC, Correa RG. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation [Internet]. BMC Genomics. 2019 ; 20( 1): 1-20 art. 152.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1186/s12864-019-5523-6

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024